hiv-infections

Documents about hiv-infections

• A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides#830297ClinicalTrials.gov
• The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer#865669ClinicalTrials.gov
• A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection#853930ClinicalTrials.gov
• Towards ending tuberculosis in South Africa: an uncertainty analysis of the programmes and factors most critical to future declines.#469559PubMed
• A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)#849271ClinicalTrials.gov
• Faisability and Efficacity of the Reinforced Communautary Support Program (PARC) on the Complications of Chemsex#849473ClinicalTrials.gov
• Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.#880410ClinicalTrials.gov
• Puerto Rico Cuidalos Parent-adolescent Program#883287ClinicalTrials.gov
• A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes#879985ClinicalTrials.gov
• A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.#390944ClinicalTrials.gov
• Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana#411635Figshare
• A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3#847624ClinicalTrials.gov
• Longitudinal analysis of viral suppression before, during, and after pregnancy among women on antiretroviral therapy in Uganda: six-year real-world experience.#9903PubMed
• Age-17 Follow-up of Home Visiting Intervention#846348ClinicalTrials.gov
• A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.#903825ClinicalTrials.gov
• A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients#868494ClinicalTrials.gov
• A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients#892401ClinicalTrials.gov
• Meeting on facilitating the adoption of the new WHO recommendations for HIV, viral hepatitis and STI interventions in the Eastern Mediterranean Region#429102WHO IRIS
• Regional distributions of chemsex, broader sexualised substance use and individual-level substance use patterns and their associations with HIV among men who have sex with men in the Netherlands: a Bayesian spatial ecological modelling and a latent class analysis.#786158PubMed
• A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV#837760ClinicalTrials.gov
• A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV#849728ClinicalTrials.gov
• Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)#872401ClinicalTrials.gov
• Data for: "Integrating point-of-care screening for curable sexually transmitted infections with HIV, syphilis and hepatitis B screening in antenatal care services in Zimbabwe: a mixed-methods process evaluation"#374982LSHTM Data Compass
• Антиретровирусная терапия ВИЧ-инфекции у взрослых и подростков: Рекомендации с позиций Общественного здравоохранения. Пересмотренное издание 2010 г.#376868WHO IRIS
• Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma#843234ClinicalTrials.gov
• The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine#861748ClinicalTrials.gov
• Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II#880254ClinicalTrials.gov
• A Study of the Effects of Advantage 24 on the Rectum#891386ClinicalTrials.gov
• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)#886799ClinicalTrials.gov
• Translating community research into global policy reform for national action: a checklist for community engagement to implement the WHO consolidated guideline on the sexual and reproductive health and rights of women living with HIV#381547WHO IRIS
• A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59#868823ClinicalTrials.gov
• A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS#143598ClinicalTrials.gov
• A Simple Intervention to Increase Persistence on PrEP in MSM to Improve Decision Making#826683ClinicalTrials.gov
• An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access#854204ClinicalTrials.gov
• Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants#859673ClinicalTrials.gov
• Maternal and birth outcomes in pregnant people with and without HIV in the Western Cape, South Africa#359113SUNScholar
• Transition to dolutegravir-based ART in 35 low- and middle-income countries : a global survey of HIV care clinics.#361127SUNScholar
• Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1–Infected Women#642151eScholarship
• A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus#238201ClinicalTrials.gov
• Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706#249686ClinicalTrials.gov
• Health system and social determinants influencing potential PrEP access among young men in rural Mpumalanga, South Africa: a qualitative analysis.#331271PubMed
• Guide du conseil et du dépistage du VIH à l' initiative du soignant dans les établissements de santé#381555WHO IRIS
• The factor structure of the Centre for Epidemiological Studies Depression Scale (CESDR- 20) among South African antiretroviral therapy users#447045SUNScholar
• A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems#826955ClinicalTrials.gov
• A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems#833728ClinicalTrials.gov
• A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex#869033ClinicalTrials.gov
• Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy#894186ClinicalTrials.gov
• Testing the WeCare Intervention to Address Mental Health and Medication Adherence Challenges Among MSM in South Africa#904489ClinicalTrials.gov
• A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)#180206ClinicalTrials.gov
• Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)#123521ClinicalTrials.gov